GSE95077 amiloride 5 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE95077_amiloride_5_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE95077_amiloride_5_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE95077_amiloride_5_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE95077_amiloride_5_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

G protein signaling modulator 3

Gene

long intergenic non-protein coding RNA 839

Gene

FSHD region gene 1 family member C, pseudogene

Gene

family with sequence similarity 225 member A

Gene

HOXA cluster antisense RNA 3

Gene

long intergenic non-protein coding RNA 3052

Gene

RNA polymerase II subunit J4 (pseudogene)

Gene

MT-CO1 pseudogene 12

Gene

TSPEAR antisense RNA 1

Gene

ZFHX4 antisense RNA 1

  • Gene

    G protein signaling modulator 3


  • Gene

    long intergenic non-protein coding RNA 839


  • Gene

    FSHD region gene 1 family member C, pseudogene


  • Gene

    family with sequence similarity 225 member A


  • Gene

    HOXA cluster antisense RNA 3


  • Gene

    long intergenic non-protein coding RNA 3052


  • Gene

    RNA polymerase II subunit J4 (pseudogene)


  • Gene

    MT-CO1 pseudogene 12


  • Gene

    TSPEAR antisense RNA 1


  • Gene

    ZFHX4 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.